Hemagen Diagnostics (Hemagen Diagnostics) Effective Interest Rate on Debt % : 9.55% (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Hemagen Diagnostics's annualized positive value of Interest Expense for the quarter that ended in Sep. 2012 was $0.48 Mil. Hemagen Diagnostics's average total debt for the quarter that ended in Sep. 2012 was $5.03 Mil. Therefore, Hemagen Diagnostics's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2012 was 9.55%.

Hemagen Diagnostics Effective Interest Rate on Debt % Historical Data

The historical data trend for Hemagen Diagnostics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Effective Interest Rate on Debt % Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

8.44

8.87

7.44

8.88

9.62

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															9.49	9.61	9.47	9.63	9.55

Competitive Comparison of Hemagen Diagnostics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Hemagen Diagnostics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Effective Interest Rate on Debt % falls into.

Hemagen Diagnostics Effective Interest Rate on Debt % Calculation

Hemagen Diagnostics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2012 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Sep. 2011 )	+	Total Debt (A: Sep. 2012 ))	/ count )
=	-1 * -0.469	/	( (4.719	+	5.027)	/ 2 )
=	-1 * -0.469	/	4.873
=	9.62 %

where

	Total Debt (A: Sep. 2011 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	4.05	+	0.669
=	4.719

	Total Debt (A: Sep. 2012 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	4.05	+	0.977
=	5.027

Hemagen Diagnostics's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2012 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2012 )	+	Total Debt (Q: Sep. 2012 ))	/ count )
=	-1 * -0.48	/	( (5.027	+	5.027)	/ 2 )
=	-1 * -0.48	/	5.027
=	9.55 %

where

	Total Debt (Q: Jun. 2012 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	4.05	+	0.977
=	5.027

	Total Debt (Q: Sep. 2012 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	4.05	+	0.977
=	5.027

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2012) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Hemagen Diagnostics (OTCPK:HMGN) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Hemagen Diagnostics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines